News

Why biotechs need a practical approach to going public

March 11, 2022

David Diamond, audit committee chair and board member of Kreston Global US member, CBIZ MHM, has been published recently in Life Science Leader. David discusses the fast-track to the public market some bio-tech companies are now experiencing, after a renewed interest in the industry.

Read the article here (membership needed).